Eterna Therapeutics Inc
For the period ended Dec 31, 2023. Filed Mar 14, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 14, 2024
ERNA$2.05+9.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
| ITEM 9B. | Other Information |
|---|
During the period from October 1, 2023, to December 31, 2023, none of our executive officers or directors adopted orterminated contracts, instructions or written plans for the purchase or sale of our securities.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.